US Patent 7919625 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (CML)

Patent 7919625 was granted and assigned to Wyeth on April, 2011 by the United States Patent and Trademark Office.

Is a

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

April 5, 2011

Patent Application Number

12139834

Date Filed

June 16, 2008

Patent Primary Examiner

Patent abstract

Compounds of the formula:

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 7919625 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (CML)

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.